1. Home
  2. INBX vs TCI Comparison

INBX vs TCI Comparison

Compare INBX & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • TCI
  • Stock Information
  • Founded
  • INBX 2010
  • TCI 1983
  • Country
  • INBX United States
  • TCI United States
  • Employees
  • INBX N/A
  • TCI N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • TCI Real Estate
  • Sector
  • INBX Health Care
  • TCI Finance
  • Exchange
  • INBX Nasdaq
  • TCI Nasdaq
  • Market Cap
  • INBX 218.9M
  • TCI 251.5M
  • IPO Year
  • INBX 2020
  • TCI N/A
  • Fundamental
  • Price
  • INBX $13.92
  • TCI $29.26
  • Analyst Decision
  • INBX Hold
  • TCI
  • Analyst Count
  • INBX 1
  • TCI 0
  • Target Price
  • INBX N/A
  • TCI N/A
  • AVG Volume (30 Days)
  • INBX 81.4K
  • TCI 5.3K
  • Earning Date
  • INBX 11-14-2024
  • TCI 11-07-2024
  • Dividend Yield
  • INBX N/A
  • TCI N/A
  • EPS Growth
  • INBX N/A
  • TCI N/A
  • EPS
  • INBX 119.38
  • TCI 0.37
  • Revenue
  • INBX $1,568,000.00
  • TCI $49,821,000.00
  • Revenue This Year
  • INBX N/A
  • TCI N/A
  • Revenue Next Year
  • INBX N/A
  • TCI N/A
  • P/E Ratio
  • INBX $0.12
  • TCI $75.22
  • Revenue Growth
  • INBX 19.24
  • TCI 4.46
  • 52 Week Low
  • INBX $10.80
  • TCI $26.29
  • 52 Week High
  • INBX $18.95
  • TCI $43.40
  • Technical
  • Relative Strength Index (RSI)
  • INBX 38.33
  • TCI 55.63
  • Support Level
  • INBX $14.53
  • TCI $27.82
  • Resistance Level
  • INBX $15.24
  • TCI $31.00
  • Average True Range (ATR)
  • INBX 0.72
  • TCI 1.00
  • MACD
  • INBX -0.10
  • TCI 0.04
  • Stochastic Oscillator
  • INBX 19.16
  • TCI 50.29

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: